Inter will partner with Italian laboratory medicine company for the 2021-22 season, with the Italian company assisting the club with COVID-19 screening and testing procedures.
This is confirmed by the club in a statement on their official site, where they announce that the Italian company will be the official partners for next summer as the club look to mitigate risks posed by COVID-19.
The aim of the new partnership will be to ensure that the upcoming season is not in any way affected by the health risks associated with COVID-19, that the players’ and staff’s health is prioritized, and that there are not significant disruptions to the season.
Since the beginning of the pandemic, there have been significant problems associated with COVID, including player absences due to positive tests, outbreaks, cancelled fixtures, and so on throughout European football, and the partnership represents an important step by the club to ensure that these issues are minimized.
